Ricci, Caterina
 Distribuzione geografica
Continente #
NA - Nord America 1.373
EU - Europa 1.132
AS - Asia 962
SA - Sud America 153
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 26
OC - Oceania 4
Totale 3.700
Nazione #
US - Stati Uniti d'America 1.335
SG - Singapore 420
IT - Italia 356
DE - Germania 235
CN - Cina 204
BR - Brasile 130
SE - Svezia 112
VN - Vietnam 101
FR - Francia 95
GB - Regno Unito 60
PL - Polonia 60
IN - India 53
FI - Finlandia 46
BD - Bangladesh 41
HK - Hong Kong 37
IE - Irlanda 35
UA - Ucraina 31
ID - Indonesia 28
RU - Federazione Russa 25
CA - Canada 19
NL - Olanda 19
JP - Giappone 18
BE - Belgio 13
KR - Corea 13
MX - Messico 13
AR - Argentina 11
AT - Austria 11
ES - Italia 11
ZA - Sudafrica 10
IQ - Iraq 8
IR - Iran 6
MA - Marocco 6
TR - Turchia 6
PK - Pakistan 5
RO - Romania 5
AU - Australia 4
CH - Svizzera 4
SA - Arabia Saudita 4
VE - Venezuela 4
EC - Ecuador 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
AW - Aruba 2
CI - Costa d'Avorio 2
HU - Ungheria 2
JM - Giamaica 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BG - Bulgaria 1
BS - Bahamas 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.651
Città #
Singapore 249
Ashburn 189
Chandler 131
San Jose 113
Rome 61
Warsaw 57
New York 53
Beijing 44
The Dalles 37
Dublin 36
Milan 35
Council Bluffs 32
Ho Chi Minh City 31
Hong Kong 30
Hefei 29
Los Angeles 29
Ann Arbor 28
Bar Harbor 28
Helsinki 28
Hanoi 27
Hyderabad 26
Jacksonville 26
Jakarta 26
Lauterbourg 25
San Mateo 21
Fairfield 20
Frankfurt am Main 20
Munich 19
Tokyo 18
Chicago 17
Houston 17
Marseille 16
Wilmington 15
Moscow 14
Santa Clara 14
Bremen 13
Nürnberg 13
Dearborn 12
Redwood City 12
Toronto 12
Boston 11
Buffalo 11
Nanjing 11
Orem 11
Atlanta 10
Brussels 10
Düsseldorf 10
Pescara 10
Woodbridge 10
Cambridge 9
Dallas 9
Princeton 9
Seoul 9
São Paulo 9
Boardman 8
Chennai 8
Johannesburg 8
Phoenix 8
Turku 8
Washington 8
Brooklyn 7
Kent 7
London 7
Mexico City 7
Paris 7
Seattle 7
Amsterdam 6
Denver 6
Pisa 6
Tukwila 6
Vienna 6
Busto Arsizio 5
Cattolica 5
Da Nang 5
Manchester 5
Portsmouth 5
Roubaix 5
Curitiba 4
Detroit 4
Guangzhou 4
Haiphong 4
Izmir 4
Lancaster 4
Lappeenranta 4
Madrid 4
Mcallen 4
New Haven 4
Nuremberg 4
Poplar 4
Ribeirão Preto 4
Stockholm 4
Allumiere 3
Amman 3
Asti 3
Baltimore 3
Baronissi 3
Cardiff 3
Castellanza 3
Catania 3
Changsha 3
Totale 1.995
Nome #
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 320
NEOPLASIE DELLA VULVA E DELLA VAGINA 304
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 202
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 192
Hpv and cytology testing in women undergoing 9-valent hpv opportunistic vaccination: A single-cohort follow up study 189
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 186
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 172
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 166
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 155
Advanced and recurrent endometrial cancer: State of the art and future perspectives 145
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 143
Cancer and Mediterranean Diet: A Review 126
Colposcopy Accuracy and Diagnostic Performance: A Quality Control and Quality Assurance Survey in Italian Tertiary-Level Teaching and Academic Institutions—The Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV) 126
Recent progress in the use of pharmacotherapy for endometrial cancer 123
PARP Inhibitors Resistance: Mechanisms and Perspectives 123
Locally Advanced Cervical Cancer in Pregnancy 115
Health utilities lost and risk factors associated with HPV-induced diseases in men and women: The HPV Italian collaborative study group 114
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon? 113
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer 109
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 102
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 95
Are we facing a new colposcopic practice in the HPV vaccination era? Opportunities, challenges, and new perspectives 95
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 81
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 79
Long-term efficacy and safety of human papillomavirus vaccination 75
Major predictive factors for recurrence of CIN after treatment: an exploratory analysis towards a predictive model 50
Totale 3.700
Categoria #
all - tutte 15.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022158 0 8 5 12 6 10 3 25 7 18 18 46
2022/2023449 48 56 22 64 21 63 23 30 62 17 30 13
2023/2024325 13 52 24 27 10 47 40 13 9 10 26 54
2024/2025605 24 6 61 22 47 24 35 21 65 105 118 77
2025/20261.397 160 33 69 142 230 88 260 85 120 89 78 43
2026/2027132 89 43 0 0 0 0 0 0 0 0 0 0
Totale 3.700